Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Investigate the Safety of the CAROL Device for Lung Tumour Treatment in Patients With Non-small Cell Lung Cancer Tumours(s) ≤ 2 cm (cT1b)

NCT07122258 is registered in ClinicalTrials.gov with Tau Medical Australia Pty Ltd as lead sponsor.

NCT NCT07122258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Investigate the Safety of the CAROL Device for Lung Tumour Treatment in Patients With Non-small Cell Lung Cancer Tumours(s) ≤ 2 cm (cT1b)
Lead sponsor
Tau Medical Australia Pty Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
June 1, 2027
Enrollment
7 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc (non-small cell lung cancer)